DUBLIN--(BUSINESS WIRE)--The "Erleada - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.
Erleada - Drug Insight, 2019 report provides comprehensive information of the drug, Erleada.
It includes drugs overview, Erleada mechanism of action, clinical trials, regulatory milestones, deals & Erleada's partnerships. It further provides Erleada's patents (US & EU) and its API manufacturers details in the United States, Europe, China and India.
It also features the historical and forecasted Erleada sales till 2021. The report also throws light on Erleada market competition and emerging therapies in the same space as Erleada. Erleada SWOT analysis is also featured.
Scope of the Report
- A comprehensive Erleada overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
- Erleada Patent information in United States (US) and Europe (EU) has been highlighted
- Erleada API manufacturers in United States, Europe, China and India
- The report contains historical and forecasted Erleada sales till 2021
- Comprehensive coverage of the emerging therapies (Phase III) in the space where Erleada operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
- The report also features the Erleada SWOT analysis
Reasons to Buy
- Establish a comprehensive understanding of the drug, Erleada
- Access to Erleada API manufacturers details to devise API procurement strategy for generic development
- Plan developmental timelines around Erleada patents for the major markets- US and EU
- Understand current and future Erleada's growth through its historical and forecasted sales
- Identify and understand the current in-market competitors for Erleada
- Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
- Identify and plan ahead for prospective emerging players and their products operating in the same space as Erleada
- Identify opportunities in the same area as with Erleada SWOT analysis
Key Topics Covered
1. Report Introduction
2. Erleada - Overview
- Erleada Product Description
- Erleada Route of Synthesis
- Erleada Mechanism of Action
- Erleada Pharmacology
- Erleada Pharmacodynamics
- Erleada Pharmacokinetics
- Erleada Adverse Reactions
- Erleada Clinical Trials
- Erleada Regulatory Milestones
- Erleada Development Activities
3. Global API Manufacturers
- United States
- Europe
- China
- India
4. Product Details
- United States
- Europe
5. Erleada Global Sales Assessment
- Erleada Sales Global(Historical)
- Erleada Sales Global(Forecasted)
6. Erleada Patent Details
7. Erleada Market Competition
8. Erleada Emerging Therapies
8.1. Drug name: Company name
- Product Description
- Research & Development
- Product Development Activities
9. Erleada SWOT Analysis
List of Tables
Table 1: Erleada, Description
Table 2: API Manufacturers Region wise
Table 3: API Manufacturers for United States
Table 4: API Manufacturers for Europe
Table 5: API Manufacturers for China
Table 6: API Manufacturers for India
Table 7: Erleada Product Details, United States
Table 8: Erleada Product Details, Europe
Table 9: Erleada, Historical Global Sales till 2017 (in million USD)
Table 10: Erleada, Forecasted Global Sales from 2019-2021 (in million USD)
Table 11: Patent Details: Erleada
Table 12: Erleada Major Competitors
Table 13: Emerging Therapies
List of Figures
Figure 1: Erleada
Figure 2: Erleada, Historical Global Sales till 2017 (in million USD)
Figure 3: Erleada, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 4: Patent Details: Erleada
Figure 5: API Manufacturers Region wise
For more information about this report visit https://www.researchandmarkets.com/r/d8yevb
